Deciphering the radiobiology of targeted radionuclide therapy: from subcellular to intra-tumoural analyses

Project Information

RADIOBIO

Grant agreement ID: 101042537

DOI

10.3030/101042537

EC signature date 28 January 2022

Start date 1 June 2022

End date 31 May 2027

Funded under

• European Research Council (ERC)

Total cost

€ 1 750 000,00

EU contribution

€ 1 750 000,00

Coordinated by

ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Netherlands

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Documents, reports (1)

Data management plan

Data management plan finalized

Publications

Peer reviewed articles (2)

Evaluating the immune response after targeted radionuclide therapy: towards a correlation between absorbed dose and response

Author(s): Justine Perrin, Nina Overdevest, Giulia Tamborino, Julie Nonnekens
Published in: International Journal of Radiation Oncology*Biology*Physics, 2025, ISSN 0360-3016
Publisher: Elsevier BV
DOI: 10.1016/J.IJROBP.2025.06.3855

Establishing In Vitro Dosimetric Models and Dose–Effect Relationships for¹⁷⁷Lu-DOTATATE in Neuroendocrine Tumors

Author(s): Giulia Tamborino, Pleun Engbers, Tijmen H. de Wolf, Thom G.A. Reuvers, Rob Verhagen, Mark Konijnenberg, Julie Nonnekens
Published in: Journal of Nuclear Medicine, 2025, ISSN 0161-5505
Publisher: Society of Nuclear Medicine
DOI: 10.2967/JNUMED.125.269470